Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPR
Spirit AeroSystems
SPR
|
+$18.4M |
| 2 |
DF
Dean Foods Company
DF
|
+$17.8M |
| 3 |
GameStop
GME
|
+$16M |
| 4 |
Amdocs
DOX
|
+$14.3M |
| 5 |
FTR
Frontier Communications Corp.
FTR
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$23.5M |
| 2 |
United Therapeutics
UTHR
|
+$16M |
| 3 |
Abercrombie & Fitch
ANF
|
+$13M |
| 4 |
American Eagle Outfitters
AEO
|
+$11M |
| 5 |
OUTR
OUTERWALL INC
OUTR
|
+$9.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.78% |
| 2 | Technology | 19.27% |
| 3 | Consumer Discretionary | 17.3% |
| 4 | Healthcare | 11.45% |
| 5 | Consumer Staples | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Flowserve
FLS
$10.1B
| $1.16M | 0.03% |
14,716
+3,736
| +34% | +$259K |
|
602
Charles River Laboratories
CRL
$14.1B
| $1.15M | 0.03% |
21,759
-19,695
| -48% | -$989K |
|
|
PGI
603
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $1.14M | 0.03% |
98,581
-17,985
| -15% | -$177K |
|
604
Ziff Davis
ZD
$1.92B
| $1.14M | 0.03% |
26,245
-34,278
| -57% | -$1.48M |
|
|
SRDX
605
DELISTED
Surmodics
SRDX
| $1.14M | 0.03% |
46,744
-8,163
| -15% | -$192K |
|
|
HNGR
606
DELISTED
Hanger Inc.
HNGR
| $1.14M | 0.03% |
28,859
+775
| +3% | +$28.4K |
|
|
COL
607
DELISTED
Rockwell Collins
COL
| $1.13M | 0.03% |
15,263
-33,219
| -69% | -$2.36M |
|
|
LIFE
608
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $1.13M | 0.03% |
14,885
+11,344
| +320% | +$856K |
|
609
SunCoke Energy
SXC
$822M
| $1.12M | 0.03% |
49,237
-48,231
| -49% | -$995K |
|
|
MSB
610
Mesabi Trust
MSB
$299M
| $1.12M | 0.03% |
50,313
-42,720
| -46% | -$947K |
|
611
Bath & Body Works
BBWI
$3.92B
| $1.08M | 0.03% |
21,662
-125
| -0.6% | -$6.25K |
|
612
NACCO Industries
NC
$309M
| $1.08M | 0.03% |
+76,120
| New | +$1.03M |
|
613
Semtech
SMTC
$11.6B
| $1.08M | 0.03% |
42,783
-129,433
| -75% | -$3.82M |
|
|
STJ
614
DELISTED
St Jude Medical
STJ
| $1.07M | 0.03% |
17,326
-9,749
| -36% | -$565K |
|
615
AptarGroup
ATR
$8.57B
| $1.05M | 0.03% |
+15,516
| New | +$990K |
|
616
Moog Inc Class A
MOG.A
$12.3B
| $1.05M | 0.02% |
+15,401
| New | +$970K |
|
|
NWY
617
DELISTED
New York & Co Inc
NWY
| $1.04M | 0.02% |
237,893
-27,625
| -10% | -$138K |
|
|
ABAX
618
DELISTED
Abaxis Inc
ABAX
| $1.03M | 0.02% |
+25,721
| New | +$950K |
|
|
MXIM
619
DELISTED
Maxim Integrated Products
MXIM
| $1.02M | 0.02% |
36,716
+29,667
| +421% | +$858K |
|
620
Mettler-Toledo International
MTD
$28B
| $1.02M | 0.02% |
4,219
+2,675
| +173% | +$653K |
|
|
SRCL
621
DELISTED
Stericycle Inc
SRCL
| $1.02M | 0.02% |
+8,803
| New | +$1.03M |
|
622
Lumen
LUMN
$6.13B
| $1.02M | 0.02% |
32,096
+695
| +2% | +$22.2K |
|
|
MFRM
623
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
| $1.02M | 0.02% |
23,714
+905
| +4% | +$32.4K |
|
624
ExxonMobil
XOM
$679B
| $1.02M | 0.02% |
10,042
-17,938
| -64% | -$1.66M |
|
625
Strategy Inc
MSTR
$47.4B
| $1.01M | 0.02% |
+81,590
| New | +$961K |
|
Similar funds
Joel Greenblatt's Q4 2013 Portfolio in Review
As of Q4 2013, Joel Greenblatt held 1,100 positions worth $4.2B, up 36% from $3.08B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Joel Greenblatt deployed $796M of net new capital in Q4 2013, opening 219 new positions and adding to 392 existing holdings. Its largest new stake was Spirit AeroSystems: 625,966 shares worth $21.3M.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was United Therapeutics, an estimated $16M trimmed.
- Joel Greenblatt's largest Q4 2013 buy was Spirit AeroSystems: 625,966 shares worth $21.3M.
- Joel Greenblatt added most to Dean Foods Company in Q4 2013, an estimated $17.8M increase.
- Joel Greenblatt's biggest Q4 2013 reduction was United Therapeutics, cutting an estimated $16M.
- Joel Greenblatt fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $23.5M.
- Joel Greenblatt's ten largest holdings make up 6.3% of its $4.2B portfolio in Q4 2013.
- Joel Greenblatt opened 219 new positions and closed 150 in Q4 2013.
- Joel Greenblatt's portfolio value rose 36% quarter-over-quarter to $4.2B.
Based on Gotham Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.